Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| NovaBay Pharmaceuticals, Inc. | 53,679,974 | reported | 16 Jan 2026 | tx 9+195,745,814 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 16 Jan 2026 | PURCHASE | NovaBay Pharmaceuticals, Inc. | 53,679,974 | 0.85 USD | deriv |
| 21 Oct 2025 | CONVERSION | NovaBay Pharmaceuticals, Inc. | 56,806,080 | 0.00 USD | |
| 16 Oct 2025 | PURCHASE | NovaBay Pharmaceuticals, Inc. | 2,702,703 | 0.00 USD | deriv |
| 21 Oct 2025 | CONVERSION | NovaBay Pharmaceuticals, Inc. | 56,806,080 | 0.00 USD | |
| 16 Oct 2025 | PURCHASE | NovaBay Pharmaceuticals, Inc. | 2,702,703 | 0.00 USD | deriv |
| 16 Oct 2025 | GRANT_AWARD | NovaBay Pharmaceuticals, Inc. | 220,663 | 0.00 USD | deriv |
| 16 Oct 2025 | GRANT_AWARD | NovaBay Pharmaceuticals, Inc. | 134,375 | 0.00 USD | deriv |